Is oxcarbazepine better than phenytoin for the treatment of dementia patients complicated with secondary epilepsy? A comparative study;¿Es la oxcarbazepina superior a la fenitoína para el tratamiento de pacientes con demencia complicada con epilepsia secundaria? Estudio comparativo

Revista Neurologica Argentina

Volumn 28, Issue 4, 2003, Pages 209-216

  Taragano, Fernando E ^a,b,c   Loñ, Leandro ^c   Sarasola, Diego ^c   Serrano, Cecilia ^b  

^a Servicio de Psiquiatría   (Argentina)

^b Servicio de Neuropsicología SIREN   (Argentina)

^c CEMIC   (Argentina)

Author keywords

Dementia; Oxcarbazepine; Phenytoin; Seizures

Indexed keywords

EID: 47949122600     PISSN: 03250938     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. INDEC. www.indec.mecon.gov.ar
2. Rabins PV, Lyketsos CG, Steele CD. "Practical Dementia Care" Oxford University Press 1999. Chapter 1. Pg.16-7.
3. Mangone CA, Allegri RF, Arizaga RL, Ollari JA. "Demencia. Enfoque Multidisciplinario" Buenos Aires. 1° Ed.1997. Parte I Pg. 37.
4. Hesdorffer DC, Hauser WA, Annegers JF, Kokmen E, Rocca WA. Dementia and adult-onset unprovoked seizures. Neurology 1996 Mar; 46(3): 727-30.
5. Romanelli MF, Morris JC, Ashkin K, Coben LA. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 1990 Aug; 47(8): 847-50.
6. Risse SC, Lampe TH, Bird TD, Nochlin D, Sumi SM, Keenan T, Cubberley L, Peskind E, Raskind MA. Myoclonus, seizures, and paratonia in Alzheimer disease. Alzheimer Dis Assoc Disord 1990 Winter; 4(4): 217-25.
7. Hesdorffer DC, Hauser WA, Annegers JF, et al. Dementia and adult-onset unprovoked seizures. Neurology. 1996; 46: 727-30.
8. Morey S. Neurologic group develops recommendations for management of epilepsy. American Family Physician, 1999, Vol. 59 Issue 9, p 2648.
9. Pharmacologic Management of Epilepsy in the Elderly. Sharya Vaughan Bourdet, Barry E. Gidal, and Brian K. Alldredge [J Am Pharm Assoc 2001; 41(3): 421-36, © 2001 American Pharmaceutical Association.
10. Lackner TE, Cloyd JC, Thomas LW, Leppik IE. Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use. Epilepsia. 1998; 39:1083-7.
11. Reinikainin kj, Keraenen T, Halonen T, Komulainen H, Rieklinen PJ. Comparision oxcarbazepine and carbamazepine: a double blind study. Epilepsy Res 1987; 1(5): 284-9.
12. Brodie MJ. Established anticonvulsants and treatment of refractory epilepsy. Lancet 1990: 336: 350-4.
13. th Ed). American Psychiatric Association Press. Washington, 1994.
14. Reisberg B, Ferris SH, De Leon MJ, Crook T. The Global Deterioration Scale for Assessment of Primary Degenerative Dementia. Am J Psychiatry, 1982; 139: 1136-39.
15. Friedman SA, Raizner AE, Rosen H, et al. Functional defects in the aging kidney. Ann Intern Med. 1972; 76: 41-5.
16. Wynne HA, Cope LH, Mutch E, et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297-301.
17. Sotaniemi EA, Arranto AJ, Pelkonen O, Pasanen M. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin Pharmacol Ther. 1997; 61: 331-9.
18. Cameron H, Macphee G. Anticonvulsant therapy in the elderly - a need for placebo controlled trials. Epilepsy Res. 1995; 21: 149-57.